Article
10 Jan 2025
ANDA Approvals
CONTRIBUTING SINCE NOVEMBER 2011
Robins Kaplan
Robins Kaplan are most popular:
- within Food, Drugs, Healthcare and Life Sciences topic(s)
- with readers working within the Banking & Credit and Pharmaceuticals & BioTech industries
COMPANY CONTENT
Article
10 Jan 2025
Navigating AI And Fiduciary Duties: 10 Key Questions For Your Organization
Article
10 Jan 2025
Silent Dangers: The Link Between Depo-Provera, Brain Tumors, And Health Inequities
Article
09 Jan 2025
How Recent Patent Damages Precedent May Increase Reasonable Royalty Awards
Article
09 Jan 2025
Astellas Pharma, Inc. v. Sandoz Inc.
Article
09 Jan 2025
New ANDA Cases
Article
09 Jan 2025
ANDA Litigation Settlements
Article
09 Jan 2025
Board Governance In The Age Of AI: Navigating Risks Of Note-Taking Tools
Article
09 Jan 2025
Destination Skiing And The DOJ's Mountain Merger Challenge
Article
09 Jan 2025
Abbreviated New Drug Applications And 505(b)(2) Applications
Article
09 Jan 2025
Stripping Away Individual Rights Through Corporate Immunity
Article
16 Dec 2024
A Landmark Victory For Disabled Homeless Veterans: Q&A With The Trial Team
Article
18 Nov 2024
Trademark Tensions On The Track: Court Upholds First Amendment Protections In Haas V. Steiner
Article
24 Sep 2024
Q&A With Alan Harter, Founder Of Pactolus Private Wealth Management
Article
14 Aug 2024
Making A Case For Trade Secret Misappropriation In The US
Article
18 Jul 2024
Amarin Pharma, Inc. v. Hikma Pharms. USA Inc.
Article
18 Jul 2024
Teva Branded Pharm. Products R&D, Inc. V. Amneal Pharms. Of NY, LLC
Article
17 Jul 2024
GENERICally Speaking: A Hatch-Waxman Litigation Bulletin
Article
17 Jul 2024
Pharmacyclics LLC v. Alvogen Pine Brook LLC
Article
12 Jul 2024
AI's Impact On Property Insurance Coverage
